Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases

Abroad (travel likely)Recruiting

Conditions

Brain Metastases From Non-small Cell Lung Cancer (NSCLC) · Brain Metastases From Melanoma · Brain Metastases From Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands
Contact: Study coordinator (Lente Kroon, MD) · neurologie@nki.nl · 0205129111
Contact: Study coordinator (Dieta Brandsma, MD, PhD)

Study leads

Dieta Brandsma, MD, PhD
Principal Investigator
Antoni van Leeuwenhoek Ziekenhuis

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

Lung Cancer · Non Small Cell Lung Cancer · Brain Metastases

Abroad (travel likely)RecruitingPHASE2

São José do Rio Preto, Brazil

Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

Non Small Cell Lung Cancer · Brain Metastases · Stereotactic Radiation

Abroad (travel likely)RecruitingPHASE2

Changsha, China

SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer

Non-Small-Cell Lung Cancer · Brain Metastases

Abroad (travel likely)Recruiting

Lianyungang, China

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer · Melanoma

Abroad (travel likely)RecruitingPHASE3

Naples, Italy · Padova, Italy